Javascript must be enabled to continue!
1795 – Course Of Dependent Patients With Buprenorphine High Dosage: About 32 Cases
View through CrossRef
IntroductionDiscussions about the limitation of the prescription and dispensing of buprenorphine hight dose (Subutex ®) emphasize the need for a systematic and formalized cooperation between the various contributors in health.ObjectiveDescribe the course of caring for patients addicted to Subutex followed at the outpatient service of Razi hospital.MethodsA retrospective study was conducted on the records of patients who consulted the outpatient service of Razi hospital during a six-month period and whose diagnosis of dependence to Subutex was retained.ResultsTwenty three patients were addicted to Subutex. 100% male. The mean age of the patients was 32.13 years. Almost 82.6% of patients had a low socioeconomic level and 78.3% of them did not have insurance. 16 were unemployed. A history of incarceration was found in 82.6% of patients. The duration of use of Subutex ranged between 2 and 168 months. Places of acquisition of this molecule were precised only by 26% of consumers. Fifteen consultants do not have any history of detoxification cure and 8 of them had 1 or 2 cures. In addition, 78.3% of patients reported being motivated to stop their addiction. Regarding collaboration of physicians, 8 patients (34% of the patients) were referred by generalist physicians, 7 patients by specialist physicians, 4 patients by emergency and 2 by psychiatrists.ConclusionThe management of patients addicted to Subutex in our country is deficient. These results argue for the necessity of general measures of support dependent on psychoactive substances.
Cambridge University Press (CUP)
Title: 1795 – Course Of Dependent Patients With Buprenorphine High Dosage: About 32 Cases
Description:
IntroductionDiscussions about the limitation of the prescription and dispensing of buprenorphine hight dose (Subutex ®) emphasize the need for a systematic and formalized cooperation between the various contributors in health.
ObjectiveDescribe the course of caring for patients addicted to Subutex followed at the outpatient service of Razi hospital.
MethodsA retrospective study was conducted on the records of patients who consulted the outpatient service of Razi hospital during a six-month period and whose diagnosis of dependence to Subutex was retained.
ResultsTwenty three patients were addicted to Subutex.
100% male.
The mean age of the patients was 32.
13 years.
Almost 82.
6% of patients had a low socioeconomic level and 78.
3% of them did not have insurance.
16 were unemployed.
A history of incarceration was found in 82.
6% of patients.
The duration of use of Subutex ranged between 2 and 168 months.
Places of acquisition of this molecule were precised only by 26% of consumers.
Fifteen consultants do not have any history of detoxification cure and 8 of them had 1 or 2 cures.
In addition, 78.
3% of patients reported being motivated to stop their addiction.
Regarding collaboration of physicians, 8 patients (34% of the patients) were referred by generalist physicians, 7 patients by specialist physicians, 4 patients by emergency and 2 by psychiatrists.
ConclusionThe management of patients addicted to Subutex in our country is deficient.
These results argue for the necessity of general measures of support dependent on psychoactive substances.
Related Results
Assessing the Safety and Efficacy of Converting Adults with Sickle Cell Disease from Full Agonist Opioids to Buprenorphine
Assessing the Safety and Efficacy of Converting Adults with Sickle Cell Disease from Full Agonist Opioids to Buprenorphine
Abstract
Background: The management of pain in adults with sickle cell disease (SCD) is complex, with the intermingling of both acute vaso-occlusive events and chron...
A prospective, randomized trial of the effect of buprenorphine continuation versus dose reduction on pain control and post-operative opioid use
A prospective, randomized trial of the effect of buprenorphine continuation versus dose reduction on pain control and post-operative opioid use
Introduction:
An increasing number of individuals are taking buprenorphine for management of opioid use disorder (OUD). Pain control can be challenging when these patie...
Basic pharmacology of buprenorphine
Basic pharmacology of buprenorphine
Buprenorphine is a derivative of the morphine alkaloid thebaine. The plasma elimination half‐life of buprenorphine is three times longer than that of the active metabolite, norbupr...
The Effects of Prenatal Buprenorphine Exposure on the Neurobehavioral Development of the Child
The Effects of Prenatal Buprenorphine Exposure on the Neurobehavioral Development of the Child
Background: Current guidelines for pregnant women with substance use disorder advise prenatal maintenance of opioid agonist therapy with either buprenorphine or methadone. Despite ...
Ketamine-Assisted Buprenorphine Initiation: A Pilot Case Series
Ketamine-Assisted Buprenorphine Initiation: A Pilot Case Series
AbstractBackground:Many people with opioid use disorder who stand to benefit from buprenorphine treatment fail to initiate it due to experience with or fear of both spontaneous opi...
Using Extended Release Buprenorphine Injection to Discontinue Sublingual Buprenorphine: A Case Series
Using Extended Release Buprenorphine Injection to Discontinue Sublingual Buprenorphine: A Case Series
Buprenorphine is highly effective for the treatment of opioid use disorder and is increasingly being used in the treatment of chronic pain. For various reasons, patients on bupreno...
Retention in opioid agonist treatment: a rapid review and meta-analysis comparing observational studies and randomized controlled trials
Retention in opioid agonist treatment: a rapid review and meta-analysis comparing observational studies and randomized controlled trials
Abstract
Background
Although oral opioid agonist therapies (OATs), buprenorphine and methadone, are effective first-line treatments, OAT remains lar...
Buprenorphine-Precipitated Withdrawal Among Hospitalized Patients Using Fentanyl
Buprenorphine-Precipitated Withdrawal Among Hospitalized Patients Using Fentanyl
ImportanceBuprenorphine treatment of opioid use disorder (OUD) is safe and effective, but opioid withdrawal during treatment initiation is associated with poor retention in care. A...

